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Purpose: Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous retinal disorder. Despite tremendous
knowledge about the genes involved in RP, little is known about the genetic causes of RP in Indonesia. Here, we aim to
identify the molecular genetic causes underlying RP in a small cohort of Indonesian patients, using genome-wide
homozygosity mapping.
Methods: DNA samples from affected and healthy individuals from 14 Indonesian families segregating autosomal
recessive, X-linked, or isolated RP were collected. Homozygosity mapping was conducted using Illumina 6k or Affymetrix
5.0 single nucleotide polymorphism (SNP) arrays. Known autosomal recessive RP (arRP) genes residing in homozygous
regions and X-linked RP genes were sequenced for mutations.
Results: In ten out of the 14 families, homozygous regions were identified that contained genes known to be involved in
the pathogenesis of RP. Sequence analysis of these genes revealed seven novel homozygous mutations in ATP-binding
cassette, sub-family A, member 4 (ABCA4), crumbs homolog 1 (CRB1), eyes shut homolog (Drosophila) (EYS), c-mer
proto-oncogene tyrosine kinase (MERTK), nuclear receptor subfamily 2, group E, member 3 (NR2E3) and
phosphodiesterase 6A, cGMP-specific, rod, alpha (PDE6A), all segregating in the respective families. No mutations were
identified in the X-linked genes retinitis pigmentosa GTPase regulator (RPGR) and retinitis pigmentosa 2 (X-linked
recessive; RP2).
Conclusions: Homozygosity mapping is a powerful tool to identify the genetic defects underlying RP in the Indonesian
population. Compared to studies involving patients from other populations, the same genes appear to be implicated in the
etiology of recessive RP in Indonesia, although all mutations that were discovered are novel and as such may be unique
for this population.
Retinitis pigmentosa (RP), a group of clinically diverse
progressive retinal disorders, is a major cause of inherited
blindness, affecting 1.5 million people worldwide. RP is
initially characterized by night blindness, followed by a
gradual loss of peripheral vision and eventually leading to
legal blindness [1]. Generally, the manifestation of the first
symptom occurs in childhood or early adulthood. The main
clinical characteristics of RP are bone-spiculed
pigmentations, attenuation of retinal vessels, a waxy pallor
appearance of the optic disc, and absent or severely reduced
a-waves on electroretinography.
Correspondence to: Rob W.J. Collin, Department of Human
Genetics, Radboud University Nijmegen Medical Centre, Geert
Grooteplein 10 6525 GA Nijmegen, the Netherlands; Phone: +31 24
3617431; FAX: +31 24 3668752; email: r.collin@antrg.umcn.nl
Genetically, RP is also very diverse, with over 50
different causative genes identified to date, and is inherited in
an autosomal dominant (30%–40%), an autosomal recessive
or isolated (50%–60%), an X-linked (5%–20%), or very rarely
in a mitochondrial or digenic manner [2]. Due to the relatively
high rate of marriages within specific ethnic groups,
autosomal recessive inheritance was reported to be even more
frequent in Indonesia [3]. A significant fraction of the
causative autosomal recessive RP (arRP) genes have been
identified using homozygosity mapping in large, often
consanguineous, pedigrees. Recently, we also applied high-
resolution homozygosity mapping to identify the genetic
defect underlying arRP in non-consanguineous populations
[4-7]. Despite a tremendous knowledge on the genetic causes
of RP, little is known about the genes involved in RP in the
Indonesian population. A study published earlier this year
involved the analysis of rhodopsin (RHO) in families with an
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autosomal dominant mode of inheritance [8]. Here we
describe the molecular genetic analysis of 14 Indonesian
families segregating arRP and show that homozygosity
mapping is a powerful tool to identify causative mutations in
this population.
METHODS
Subjects: Fourteen Indonesian families segregating RP—13
living on Java and one on Sulawesi islands—were enrolled in
the study (total number of 56 individuals, 33 affected, 23
unaffected). The affected individuals were 20 males and 13
females of 10–71 years old, with the onset of the disease
ranging from the age of 5 to 25. All families appear to be
autosomal recessive, except for W09–0049, which is more
suggestive of an X-linked recessive pattern. This type of
inheritance is also possible in families W09–0048 and W09–
0050 (Figure 1). Affected individuals were diagnosed at the
Kariadi Hospital, the William Booth Hospital, or the Panti
Wilasa Citarum in Semarang Central Java, Indonesia, and
examined by direct ophthalmoscopy and visual acuity tests
using a Snellen chart. The presumed mode of inheritance was
determined by anamnesis and pedigree analysis. Informed
consent was obtained from all participating individuals or in
the case of under-age participants, from their parents. This
study adhered to the tenets of the Declaration of Helsinki. In
addition, 149 ethnically matched and unrelated control
individuals participated in this study.
Clinical characterization: Clinical characterization that
included funduscopy and visual acuity measurements
revealed that the majority of affected individuals had poor
vision and showed typical hallmarks of RP on funduscopy,
e.g., bone-spicule pigmentation, attenuated retinal vessels,
and/or a pale appearance of the optic disc (Table 1). Only in
family W09–0036 is the visual acuity not dramatically
decreased.
Linkage analysis and homozygosity mapping: Genomic DNA
of participating individuals was isolated from peripheral
blood using a standard salting out procedure [9]. Affected
individuals were selected for genome-wide single nucleotide
polymorphism (SNP) analysis. For three consanguineous
families (W09–0041, W09–0042, and W09–0046), the low-
resolution Illumina 6k SNP array (Illumina, San Diego, CA)
that contains 6,020 SNPs was used, whereas the patients from
the remaining 11 families were genotyped on a high-
resolution Affymetrix 5.0 array (Affymetrix, Santa Clara, CA)
that contains ~500,000 SNPs. For the three consanguineous
families that were analyzed on the Illumina array, multipoint
parametric linkage analysis was performed using the
GeneHunter 2.1r5 program in the easyLinkage v5.052beta
software package [10]. For the other families, homozygous
regions were calculated using PLINK software [11], with a
cut-off of 3 Mb and allowing two heterozygous SNP calls per
window of 50 SNPs.
Mutation analysis: Exons and intron–exon boundaries of all
known arRP genes residing in homozygous regions and X-
linked RP genes retinitis pigmentosa GTPase regulator
(RPGR) and retinitis pigmentosa 2 (X-linked recessive)
(RP2) were sequenced in the corresponding probands using
the Big Dye Terminator Cycle Sequencing Kit v3.1 on a 3130
automated sequencer (Applied Biosystems, Foster City, CA).
Upon identification of an unknown variant, available family
members and/or ethnically matched control individuals were
analyzed using direct sequencing, the amplification refractory
mutation system or restriction fragment length polymorphism
analysis. Primer sequences and PCR conditions are available
upon request. The analysis of mutations was conducted with
AlaMut 1.5 software (Interactive Biosoftware, Rouen,
France). Splice site scores were calculated using an internal
AlaMut module that combines the scores of GeneSplicer,
MaxEntScan, SpliceSiteFinder-like, and NNSPLICE. For the
missense changes that were identified, the evolutionary
conservation of the substituted amino acids was assessed by
aligning the corresponding protein sequences of several
species, using the Align program in VectorNTI Advance 11.0
software (Invitrogen, Carlsbad, CA). The pathogenicity of
these mutations was evaluated using SIFT [12] and
PolyPhen-2 [13] prediction programs. In addition, Grantham
scores, which define the physicochemical difference between
amino acids [14], and PhyloP scores, which are a measure of
evolutionary nucleotide conservation (PhyloP44wayAll),
were determined.
RESULTS
Linkage analysis and homozygosity mapping in arRP
families: To determine the location of the genetic defect in the
14 presumed arRP families, affected individuals were
genotyped using whole-genome SNP arrays (Figure 1). In
three consanguineous families with multiple affected
individuals (W09–0041, W09–0042, and W09–0046), the
Illumina 6k array was used. Multipoint linkage analysis was
performed to detect genomic regions that might contain the
genetic defect. In family W09–0041, only a single peak with
a maximum multipoint LOD score of 3.00 on chromosome 15
was identified (Figure 2A). In families W09–0042 and W09–
0046, multiple peaks potentially harboring the genetic defect
were identified, with multipoint LOD scores of 1.80 (Figure
2B,C). As expected in patients born from consanguineous
marriages, all regions with the highest LOD scores in the three
families represented continuous stretches of homozygous
SNP calls (Table 2), with identical haplotypes shared between
affected siblings. In the remaining 11 arRP families, high-
resolution SNP genotyping was performed using Affymetrix
5.0 arrays. Homozygous regions were calculated and
considered to be significant if they spanned more than 3 Mb
of genomic DNA. For the families with multiple affected
siblings, only those regions that were homozygous in all
affected individuals were considered to potentially harbor the
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Figure 1. Overview of the pedigree structure of the Indonesian families participating in this study. Affected individuals are indicated with
filled symbols, whereas unaffected relatives are indicated by open symbols. Symbols with a slash depict deceased individuals. Probands are
indicated with arrows, and individuals that were genotyped on genome-wide SNP arrays are marked with asterisks. Upon the identification
of mutations in the probands (gene and mutation indicated below the pedigree), segregation analysis was performed in all available relatives,
the results of which are indicated with M (mutated allele) or + (wild-type allele).
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causative gene. In four families, no regions that were
homozygous in all affected siblings were identified, whereas
in a few other families, many of those regions were present.
In the non-consanguineous families, the number of
homozygous segments per family varied from 0 to 5, with a
maximum length of 20 Mb.
Mutation analysis of autosomal recessive RP genes in
homozygous regions: In the majority of the families, one or
more homozygous regions contained one of the 31 known
arRP genes. Sequence analysis of these genes in the
corresponding families revealed seven novel mutations likely
to be causative for RP in the respective families (Table 2). The
pathogenicity of the missense and splice site mutations were
evaluated using a detailed in silico analysis (Table 3).
In family W09–0038, the largest homozygous region
contained the c-mer proto-oncogene tyrosine kinase
(MERTK) gene. Exon 15 failed to amplify in the affected
individuals but not in the unaffected family members,
suggesting a genomic deletion (Figure 3A). Detailed analysis
revealed the occurrence of a complex rearrangement that
included a 1732-bp deletion containing exon 15 of MERTK
(Figure 3B). The absence of exon 15 from MERTK mRNA is
predicted to result in a frameshift and premature stop codon,
which may lead to truncation of the MERTK protein
(p.G654AfsX41) or trigger nonsense-mediated mRNA decay.
The affected individuals of family W09–0045 displayed three
shared homozygous regions, of which the second largest
contained MERTK. Sequence analysis revealed a
homozygous mutation (c.2487–2A>G) that affects the
consensus splice site of exon 19 and most likely results in
aberrant splicing and premature termination of the MERTK
protein, including the highly conserved tyrosine kinase
domain (Table 3).
In family W09–0041, four affected siblings shared only
one large homozygous region, on chromosome 15, harboring
the nuclear receptor subfamily 2, group E, member 3
(NR2E3) gene. Mutation analysis of NR2E3 identified a
homozygous mutation substituting a glycine for a valine
residue (c.1025T>G; p.V342G). The PolyPhen-2 program
predicts this variant to be probably damaging, and SIFT
indicates that in this position only a valine or isoleucine is
tolerated (Table 3). Furthermore, the mutation was
homozygously present in five affected family members and
was absent or heterozygously present in three unaffected
siblings. Finally, this variant was not detected in 298
ethnically matched control alleles. NR2E3 encodes a
transcription factor that belongs to the family of nuclear
hormone receptors, with a DNA-binding domain (DBD) at the
N-terminus and a ligand-binding domain (LBD) located more
C-terminally [15]. Most NR2E3 mutations that cause retinal
dystrophy affect amino acid residues located in these two
domains [16]. The LBD of NR2E3 is structurally similar to
that of other nuclear hormone receptor family members and
consists of 12 structurally conserved α-helices [17,18]. The
valine residue at position 342 is highly conserved, both in the
NR2E3 proteins of other species and in the LBD of other
nuclear hormone receptors, being either a valine or a similar
isoleucine residue in all other protein sequences (Figure 4B).
This high degree of conservation suggests that a relatively
large nonpolar amino acid must be present at this position to
preserve the structure and/or function of the LBD of these
proteins. The glycine residue that is present in the mutant
NR2E3 protein is small and might interrupt the structure and
render the protein inactive or partially active. The pathogenic
character of this variant is supported by the fact that this
alteration has not been found in alleles of healthy ethnically
matched individuals.
In family W09–0042, the largest homozygous region
contains the ATP-binding cassette, sub-family A, member 4
(ABCA4) gene, which has been associated with Stargardt's
disease [19], cone-rod dystrophy, and to a lesser extent, RP
[20]. Sequence analysis revealed a nucleotide variant in the
splice donor site of exon 3 (c.302+4A>C) homozygously
present in the two affected siblings and absent or
heterozygously present in their nonaffected relatives. In
addition, the variant was not detected in 298 ethnically
matched control chromosomes. In silico prediction of the
strength of the splice donor site showed a decrease due to the
alteration (e.g., 40% decrease in GeneSplicer, 24% in
MaxEntScan, 12.3% SpliceSiteFinder-like, and 0.04%
decrease in NNSPLICE), indicating that this variant might
alter ABCA4 splicing (Table 3). However, due to the
unavailability of patient RNA or lymphoblastoid cell lines,
altered ABCA4 splicing could not be confirmed in vivo.
Hence, the pathogenicity of this variant remains uncertain.
In family W09–0046, three regions that are
homozygously shared by two affected siblings were detected.
The second largest region contained two known arRP genes,
namely tubby-like protein 1 (TULP1) and eyes shut homolog
(Drosophila) (EYS). Sequence analysis of TULP1 did not
reveal any pathogenic variants, whereas a missense variant
was detected in EYS that segregated with arRP in the family
(c.9082G>T; p.D3028Y). This alteration affects an aspartic
acid residue localized in the fifth laminin A G-like domain of
the human EYS protein. The aspartic acid residue at this
position is also present in homologous positions of other EYS
LG domains and is evolutionarily conserved in EYS proteins
of other species (Figure 4C). Both SIFT and PolyPhen-2
predict this change to be damaging, which is further supported
by high Grantham and PhyloP scores (Table 3). Intriguingly,
a similar mutation (p.D2767Y), located at the homologous
position in the fourth laminin A G-like domain of EYS, was
recently found in a Pakistani family segregating arRP [21].
This suggests that the aspartic acid residue located at that
position within the laminin A G-like domain is crucial for
proper functioning of EYS and that the p.D3028Y mutation
is indeed pathogenic in family W09–0046.
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Figure 2. Overview of linkage plots for the three consanguineous Indonesian families. The graphs depict the linkage analysis results for three
consanguineous Indonesian families, W09–0041 (A), W09–0042 (B) and W09–0046 (C) that were analyzed with Illumina 6k arrays. The
highest LOD-score peaks were identified using EasyLinkage software. Peaks that correspond to the regions harboring the genes in which
mutations were identified, are indicated with red arrows.
Molecular Vision 2011; 17:3013-3024 <http://www.molvis.org/molvis/v17/a325> © 2011 Molecular Vision
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In two affected siblings from family W09–0047, only a
single homozygous region was detected that harbored the
phosphodiesterase 6A, cGMP-specific, rod, alpha (PDE6A)
gene. A nonsense mutation (c.1675C>A; p.Y558X) was
found to segregate with RP in this family, and this is predicted
to either result in premature termination of the α subunit of
the phosphodiesterase enzyme or to cause nonsense-mediated
decay of PDE6A mRNA.
The largest homozygous region detected in the affected
individual 50068 from family W09–0048 contained the
crumbs homolog 1 (CRB1) gene, and sequence analysis
revealed a transition of cytosine to thymine, resulting in the
substitution of a leucine for a proline residue (c.3914C>T;
p.P1305L). This alteration was not detected in 149 ethnically
matched control individuals and is predicted to be probably
damaging by PolyPhen, although the SIFT software predicts
it to be tolerated (Table 3). The proline residue that is
substituted resides in one of the EGF-like calcium-binding
domains of CRB1 and neighbors one of the six core cysteine
residues that are essential for the formation of disulphide
bridges and proper structure of these domains [22]. The fact
that the proline residue is highly conserved throughout
vertebrate evolution and even in fruit fly (Figure 4A), suggests
that this mutation is causative for arRP in this family.
Figure 3. Molecular genetic analysis of MERTK in family W09–0038. A: In the upper panel, PCR analysis of exon 15 of MERTK is shown.
Exon 15 was not amplified in the two affected individuals of family W09–0038. All relatives and their position in the pedigree are indicated
above the electropherogram. Lower panel: after identification of the breakpoints of the complex rearrangement, PCR primers were designed
to amplify a product spanning the deletion. A PCR product indicating the presence of a rearrangement is observed in all individuals
demonstrating that the unaffected family members are heterozygous carriers of the deletion. B: Schematic representation of the complex
rearrangement in MERTK. A deletion of a genomic region containing exon 15 is accompanied by a duplication and an inversion event.
Figure 4. Sequence comparison of amino acids mutated in Indonesian RP families. The mutated and flanking amino acids, from orthologous
and homologous protein sequences, for A: CRB1 B: NR2E3 and C: EYS. The arrows indicate the position of the mutated amino acid residue
in the alignment. Residues that are conserved in all protein sequences are depicted in white on a black background, whereas residues that are
conserved in more than 50% of the analyzed sequences are indicated in black on a gray background.
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In two of the families (W09–0049 and W09–0050), genes
residing in the largest homozygous regions (family with
sequence similarity 161, member A [FAM161A], ABCA4,
retinal pigment epithelium-specific protein 65 kDa [RPE65],
Usher syndrome 2A (autosomal recessive, mild) [USH2A],
and progressive rod-cone degeneration [PRCD]) were
excluded. Four families (W09–0036, W09–0039, W09–0040,
and W09–0044) had no significant homozygous regions.
For the families with plausible X-linked inheritance
(W09–0048, W09–0049 and W09–0050), we performed
screening of the two known X-linked RP genes. RP2 and
RPGR were sequenced, but no mutations were identified.
DISCUSSION
In this study we analyzed the molecular genetic causes of RP
in 14 Indonesian families with an apparent recessive mode of
inheritance; especially in the simplex families, de novo
mutations or an X-linked inheritance cannot be ruled out.
In all 14 families, genome-wide homozygosity mapping
was performed to find genomic regions potentially harboring
the causative genetic defect. In ten of the 14 families,
significant homozygous regions were detected in the affected
individuals, ranging from 3.4 to 69.5 Mb in size (Table 2). On
average, European populations, which are mostly outbred,
display a total of about 93 Mb of genomic runs of
homozygosity (ROH) longer than 0.5 Mb, corresponding to
approximately 3.5% of the genome [23]. Unfortunately, no
such studies were conducted within the Indonesian
population. In our small cohort, these average ROH in 16
individuals from nine families without reported consanguinity
(see Figure 1) comprised 146 Mb (~5.5%) of genomic DNA,
which suggests a slightly higher level of inbreeding in this
population. Consanguineous unions within the Indonesian
culture are not uncommon. Moreover, Indonesia consists of a
large archipelago of islands, 922 of which are inhabited, which
further increases the possibility of marrying distant relatives.
Hence, our data support the hypothesis that the Indonesian
population is highly suited for a homozygosity mapping
approach to determine genetic defects underlying recessive
diseases.
In nine families, the homozygous regions contained one
or more of the 31 known arRP genes. Sequence analysis of all
these genes in the corresponding probands revealed
potentially pathogenic mutations in seven families. A
homozygous nonsense mutation in PDE6A, a canonical splice
mutation in MERTK, and a complex rearrangement in
MERTK are three mutations that are undoubtedly pathogenic
in the respective families. The causality of the novel three
missense and one splice donor mutation is not obvious. The
pathogenic effect of missense alterations may be difficult to
interpret in the absence of suitable functional assays or animal
models. However, due to the high degree of conservation of
the mutated amino acid residues, their location within
predicted functional domains of the encoded proteins, and the
absence of these alleles in ethnically matched control
individuals, the missense variants in CRB1, EYS, and
NR2E3 are considered to be the probable pathogenic mutation
in the respective families. The splice alteration in ABCA4 (c.
302+4A>C) was also not detected in Indonesian controls, and
the strength of the splice donor site was predicted to be
decreased by several splice-site strength prediction programs.
The fourth nucleotide of an intron in primates is an adenine in
71% of the cases, a guanine in 12%, and a cytosine in only 8%
[24]. Therefore, the strength of the splice donor site in
ABCA4 may be reduced due to the A-to-C transition at that
position. However, reverse transcriptase (RT)-PCR analysis
on patient-derived RNA is necessary to confirm pathogenicity
of this variant in the respective family.
The identification of genetic events underlying RP was
previously clinically useful only in genetic counseling.
However, with the successful development of gene therapy
for retinal dystrophies, such as for Leber congenital amaurosis
due to RPE65 mutations [25-27], molecular diagnosis is of
increasing importance to enroll patients in future clinical
trials. Since RP is a progressive disease, early diagnosis is
essential, and the identification of a causative alteration will
be crucial in the near future to plan gene- or even mutation-
tailored therapy. Homozygosity mapping has been
demonstrated to be a powerful tool to detect recessive
mutations underlying RP in the Indonesian population. Based
upon the criteria of the percentage of homozygous regions in
an individual genome, which is about 50% higher than in
outbred European populations, SNP array analysis appears to
be the most practical approach. Since we have identified the
probable causative genetic defect in seven out of 14 arRP
families, using homozygosity mapping, and excluded RPGR
and RP2 in families suggestive of X-linked inheritance, some
of the other families might harbor a homozygous mutation in
a novel arRP gene, in any of their homozygous regions.
However, many of the genetically unsolved families are non-
consanguineous and do not display large homozygous
regions. Therefore, the majority of these families are likely to
carry compound heterozygous mutations, either in one of the
known arRP genes or in yet to be identified genes. Only next-
generation sequencing approaches, either on predefined
genomic regions [28] or unbiased exome sequencing [29,30],
will allow a cost- and time-efficient analysis to discover the
genetic causes underlying RP in the remaining families.
Due to the extreme heterogeneity of arRP, it is not easy
to predict the percentage of arRP cases that can be explained
by mutations in the known arRP genes, although current
estimates are around 50%. Being aware of the relatively small
size of our cohort but taking into consideration that some of
the 14 tested arRP families may carry compound
heterozygous mutations in known arRP genes or homozygous
mutations in these genes in homozygous regions smaller than
3 Mb, we can conclude that the known arRP genes appear to
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explain at least 50% of the underlying genetic defects. This
conclusion will be strengthened upon the analysis of more
families, both in the Indonesian and in other populations.
Taken together, the results described in this study have
helped to clarify the molecular genetic causes underlying
recessive RP in Indonesia and as such will be beneficial in
terms of genetic counseling, disease diagnosis, and/or disease
prognosis and in the future might help to select patients
eligible for genetic therapies to cease the progression of this
disabling disease.
ACKNOWLEDGMENTS
We gratefully acknowledge all patients and their relatives for
participating in this study. We thank Saskia D. van der Velde-
Visser for technical assistance. This study was financially
supported by the Foundation Fighting Blindness USA (grant
BR-GE-0510–0489-RAD [to A.I.dH.]) and by the
Netherlands Organisation for Scientific Research (TOP-grant
91209047 [to F.P.M.C., H. Kremer, and A.I.dH.]). K.A. is the
recipient of Beasiswa Unggulan Ministry of National
Education Government of Indonesia.
REFERENCES
1. Berson EL. Retinitis pigmentosa. The Friedenwald Lecture.
Invest Ophthalmol Vis Sci 1993; 34:1659-76. [PMID:
8473105]
2. Berger W, Kloeckener-Gruissem B, Neidhardt J. The molecular
basis of human retinal and vitreoretinal diseases. Prog Retin
Eye Res 2010; 29:335-75. [PMID: 20362068]
3. Sitorus R, Preising M, Lorenz B. Causes of blindness at the
“Wiyata Guna” School for the Blind, Indonesia. Br J
Ophthalmol 2003; 87:1065-8. [PMID: 12928266]
4. Bandah-Rozenfeld D, Collin RW, Banin E, van den Born LI,
Coene KL, Siemiatkowska AM, Zelinger L, Khan MI,
Lefeber DJ, Erdinest I, Testa F, Simonelli F, Voesenek K,
Blokland EA, Strom TM, Klaver CC, Qamar R, Banfi S,
Cremers FP, Sharon D, den Hollander AI. Mutations in
IMPG2, encoding interphotoreceptor matrix proteoglycan 2,
cause autosomal-recessive retinitis pigmentosa. Am J Hum
Genet 2010; 87:199-208. [PMID: 20673862]
5. Collin RW, Littink KW, Klevering BJ, van den Born LI,
Koenekoop RK, Zonneveld MN, Blokland EA, Strom TM,
Hoyng CB, den Hollander AI, Cremers FP. Identification of
a 2 Mb human ortholog of Drosophila eyes shut/spacemaker
that is mutated in patients with retinitis pigmentosa. Am J
Hum Genet 2008; 83:594-603. [PMID: 18976725]
6. Collin RW, Safieh C, Littink KW, Shalev SA, Garzozi HJ, Rizel
L, Abbasi AH, Cremers FP, den Hollander AI, Klevering BJ,
Ben-Yosef T. Mutations in C2ORF71 cause autosomal-
recessive retinitis pigmentosa. Am J Hum Genet 2010;
86:783-8. [PMID: 20398884]
7. Collin RW, van den Born LI, Klevering BJ, de Castro-Miró M,
Littink KW, Arimadyo K, Azam M, Yazar V, Zonneveld MN,
Paun CC, Siemiatkowska AM, Strom TM, Hehir-Kwa JY,
Kroes HY, de Faber JT, van Schooneveld MJ, Heckenlively
JR, Hoyng CB, den Hollander AI, Cremers FP. High-
resolution homozygosity mapping is a powerful tool to detect
novel mutations causative for autosomal recessive RP in the
Dutch population. Invest Ophthalmol Vis Sci 2011;
52:2227-39. [PMID: 21217109]
8. Kartasasmita A, Fujiki K, Iskandar E, Sovani I, Fujimaki T,
Murakami A. A novel nonsense mutation in rhodopsin gene
in two Indonesian families with autosomal recessive retinitis
pigmentosa. Ophthalmic Genet 2011; 32:57-63. [PMID:
21174529]
9. Miller SA, Dykes DD, Polesky HF. A simple salting out
procedure for extracting DNA from human nucleated cells.
Nucleic Acids Res 1988; 16:1215. [PMID: 3344216]
10. Hoffmann K, Lindner TH. easyLINKAGE-Plus–automated
linkage analyses using large-scale SNP data. Bioinformatics
2005; 21:3565-7. [PMID: 16014370]
11. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA,
Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham
PC. PLINK: a tool set for whole-genome association and
population-based linkage analyses. Am J Hum Genet 2007;
81:559-75. [PMID: 17701901]
12. Ng PC, Henikoff S. Predicting deleterious amino acid
substitutions. Genome Res 2001; 11:863-74. [PMID:
11337480]
13. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE,
Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A
method and server for predicting damaging missense
mutations. Nat Methods 2010; 7:248-9. [PMID: 20354512]
14. Grantham R. Amino acid difference formula to help explain
protein evolution. Science 1974; 185:862-4. [PMID:
4843792]
15. Kobayashi M, Takezawa S, Hara K, Yu RT, Umesono Y, Agata
K, Taniwaki M, Yasuda K, Umesono K. Identification of a
photoreceptor cell-specific nuclear receptor. Proc Natl Acad
Sci USA 1999; 96:4814-9. [PMID: 10220376]
16. Kanda A, Swaroop A. A comprehensive analysis of sequence
variants and putative disease-causing mutations in
photoreceptor-specific nuclear receptor NR2E3. Mol Vis
2009; 15:2174-84. [PMID: 19898638]
17. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D.
Crystal structure of the ligand-binding domain of the human
nuclear receptor RXR-alpha. Nature 1995; 375:377-82.
[PMID: 7760929]
18. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P,
Gronemeyer H, Moras D. Crystal structure of the RAR-
gamma ligand-binding domain bound to all-trans retinoic
acid. Nature 1995; 378:681-9. [PMID: 7501014]
19. Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A,
Chidambaram A, Gerrard B, Baird L, Stauffer D, Peiffer A,
Rattner A, Smallwood P, Li Y, Anderson KL, Lewis RA,
Nathans J, Leppert M, Dean M, Lupski JR. A photoreceptor
cell-specific ATP-binding transporter gene (ABCR) is
mutated in recessive Stargardt macular dystrophy. Nat Genet
1997; 15:236-46. [PMID: 9054934]
20. Cremers FP, van de Pol DJ, van Driel M, den Hollander AI, van
Haren FJ, Knoers NV, Tijmes N, Bergen AA, Rohrschneider
K, Blankenagel A, Pinckers AJ, Deutman AF, Hoyng CB.
Autosomal recessive retinitis pigmentosa and cone-rod
dystrophy caused by splice site mutations in the Stargardt's
disease gene ABCR. Hum Mol Genet 1998; 7:355-62.
[PMID: 9466990]
21. Khan MI, Collin RW, Arimadyo K, Micheal S, Azam M,
Qureshi N, Faradz SM, den Hollander AI, Qamar R, Cremers
Molecular Vision 2011; 17:3013-3024 <http://www.molvis.org/molvis/v17/a325> © 2011 Molecular Vision
3023
FP. Missense mutations at homologous positions in the fourth
and fifth laminin A G-like domains of eyes shut homolog
cause autosomal recessive retinitis pigmentosa. Mol Vis
2010; 16:2753-9. [PMID: 21179430]
22. den Hollander AI, Davis J, van der Velde-Visser SD, Zonneveld
MN, Pierrottet CO, Koenekoop RK, Kellner U, van den Born
LI, Heckenlively JR, Hoyng CB, Handford PA, Roepman R,
Cremers FP. CRB1 mutation spectrum in inherited retinal
dystrophies. Hum Mutat 2004; 24:355-69. [PMID:
15459956]
23. McQuillan R, Leutenegger AL, Abdel-Rahman R, Franklin CS,
Pericic M, Barac-Lauc L, Smolej-Narancic N, Janicijevic B,
Polasek O, Tenesa A, Macleod AK, Farrington SM, Rudan P,
Hayward C, Vitart V, Rudan I, Wild SH, Dunlop MG, Wright
AF, Campbell H, Wilson JF. Runs of homozygosity in
European populations. Am J Hum Genet 2008; 83:359-72.
[PMID: 18760389]
24. Shapiro MB, Senapathy P. RNA splice junctions of different
classes of eukaryotes: sequence statistics and functional
implications in gene expression. Nucleic Acids Res 1987;
15:7155-74. [PMID: 3658675]
25. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R,
Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler
N, Petersen-Jones S, Bhattacharya SS, Thrasher AJ, Fitzke
FW, Carter BJ, Rubin GS, Moore AT, Ali RR. Effect of gene
therapy on visual function in Leber's congenital amaurosis. N
Engl J Med 2008; 358:2231-9. [PMID: 18441371]
26. Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV,
Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne
BJ, Jacobson SG. Treatment of leber congenital amaurosis
due to RPE65 mutations by ocular subretinal injection of
adeno-associated virus gene vector: short-term results of a
phase I trial. Hum Gene Ther 2008; 19:979-90. [PMID:
18774912]
27. Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F,
Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi
S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs
J, Dell'Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck
B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe
NJ, McDonnell JW, Auricchio A, High KA, Bennett J. Safety
and efficacy of gene transfer for Leber's congenital amaurosis.
N Engl J Med 2008; 358:2240-8. [PMID: 18441370]
28. Nikopoulos K, Gilissen C, Hoischen A, van Nouhuys CE,
Boonstra FN, Blokland EA, Arts P, Wieskamp N, Strom TM,
Ayuso C, Tilanus MA, Bouwhuis S, Mukhopadhyay A,
Scheffer H, Hoefsloot LH, Veltman JA, Cremers FP, Collin
RW. Next-generation sequencing of a 40 Mb linkage interval
reveals TSPAN12 mutations in patients with familial
exudative vitreoretinopathy. Am J Hum Genet 2010;
86:240-7. [PMID: 20159111]
29. Hoischen A, van Bon BW, Gilissen C, Arts P, van Lier B,
Steehouwer M, de Vries P, de Reuver R, Wieskamp N,
Mortier G, Devriendt K, Amorim MZ, Revencu N, Kidd A,
Barbosa M, Turner A, Smith J, Oley C, Henderson A, Hayes
IM, Thompson EM, Brunner HG, de Vries BB, Veltman JA.
De novo mutations of SETBP1 cause Schinzel-Giedion
syndrome. Nat Genet 2010; 42:483-5. [PMID: 20436468]
30. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent
KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA,
Shendure J, Bamshad MJ. Exome sequencing identifies the
cause of a mendelian disorder. Nat Genet 2010; 42:30-5.
[PMID: 19915526]
Molecular Vision 2011; 17:3013-3024 <http://www.molvis.org/molvis/v17/a325> © 2011 Molecular Vision
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
The print version of this article was created on 15 November 2011. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
3024
